Esprinet Balance Sheet Health

Financial Health criteria checks 2/6

Esprinet has a total shareholder equity of €374.1M and total debt of €310.6M, which brings its debt-to-equity ratio to 83%. Its total assets and total liabilities are €1.8B and €1.4B respectively. Esprinet's EBIT is €41.1M making its interest coverage ratio 2.1. It has cash and short-term investments of €101.9M.

Key information

83.0%

Debt to equity ratio

€310.58m

Debt

Interest coverage ratio2.1x
Cash€101.95m
Equity€374.15m
Total liabilities€1.39b
Total assets€1.77b

Recent financial health updates

Recent updates

Why Esprinet's (BIT:PRT) Earnings Are Better Than They Seem

Sep 19
Why Esprinet's (BIT:PRT) Earnings Are Better Than They Seem

Here's Why Shareholders Should Examine Esprinet S.p.A.'s (BIT:PRT) CEO Compensation Package More Closely

Apr 18
Here's Why Shareholders Should Examine Esprinet S.p.A.'s (BIT:PRT) CEO Compensation Package More Closely

Returns On Capital At Esprinet (BIT:PRT) Have Hit The Brakes

Aug 29
Returns On Capital At Esprinet (BIT:PRT) Have Hit The Brakes

Returns On Capital At Esprinet (BIT:PRT) Have Stalled

May 17
Returns On Capital At Esprinet (BIT:PRT) Have Stalled

Does Esprinet (BIT:PRT) Deserve A Spot On Your Watchlist?

Apr 26
Does Esprinet (BIT:PRT) Deserve A Spot On Your Watchlist?

Esprinet S.p.A.'s (BIT:PRT) Intrinsic Value Is Potentially 73% Above Its Share Price

Mar 20
Esprinet S.p.A.'s (BIT:PRT) Intrinsic Value Is Potentially 73% Above Its Share Price

What Is Esprinet S.p.A.'s (BIT:PRT) Share Price Doing?

Feb 23
What Is Esprinet S.p.A.'s (BIT:PRT) Share Price Doing?

Returns On Capital Are Showing Encouraging Signs At Esprinet (BIT:PRT)

Nov 12
Returns On Capital Are Showing Encouraging Signs At Esprinet (BIT:PRT)

Is It Time To Consider Buying Esprinet S.p.A. (BIT:PRT)?

Oct 20
Is It Time To Consider Buying Esprinet S.p.A. (BIT:PRT)?

Here's Why We Think Esprinet (BIT:PRT) Might Deserve Your Attention Today

Sep 02
Here's Why We Think Esprinet (BIT:PRT) Might Deserve Your Attention Today

What Does Esprinet S.p.A.'s (BIT:PRT) Share Price Indicate?

Jul 06
What Does Esprinet S.p.A.'s (BIT:PRT) Share Price Indicate?

Is Esprinet (BIT:PRT) A Risky Investment?

May 25
Is Esprinet (BIT:PRT) A Risky Investment?

At €10.74, Is Esprinet S.p.A. (BIT:PRT) Worth Looking At Closely?

Feb 24
At €10.74, Is Esprinet S.p.A. (BIT:PRT) Worth Looking At Closely?

These 4 Measures Indicate That Esprinet (BIT:PRT) Is Using Debt Reasonably Well

Jan 11
These 4 Measures Indicate That Esprinet (BIT:PRT) Is Using Debt Reasonably Well

With EPS Growth And More, Esprinet (BIT:PRT) Is Interesting

Dec 14
With EPS Growth And More, Esprinet (BIT:PRT) Is Interesting

Esprinet (BIT:PRT) Hasn't Managed To Accelerate Its Returns

Nov 05
Esprinet (BIT:PRT) Hasn't Managed To Accelerate Its Returns

Esprinet (BIT:PRT) Has A Rock Solid Balance Sheet

Jul 27
Esprinet (BIT:PRT) Has A Rock Solid Balance Sheet

Here's Why I Think Esprinet (BIT:PRT) Is An Interesting Stock

Jul 15
Here's Why I Think Esprinet (BIT:PRT) Is An Interesting Stock

Should You Think About Buying Esprinet S.p.A. (BIT:PRT) Now?

May 31
Should You Think About Buying Esprinet S.p.A. (BIT:PRT) Now?

Esprinet S.p.A. (BIT:PRT) Shares Could Be 29% Above Their Intrinsic Value Estimate

May 17
Esprinet S.p.A. (BIT:PRT) Shares Could Be 29% Above Their Intrinsic Value Estimate

I Ran A Stock Scan For Earnings Growth And Esprinet (BIT:PRT) Passed With Ease

Apr 05
I Ran A Stock Scan For Earnings Growth And Esprinet (BIT:PRT) Passed With Ease

Does Esprinet (BIT:PRT) Have A Healthy Balance Sheet?

Mar 23
Does Esprinet (BIT:PRT) Have A Healthy Balance Sheet?

How Does Esprinet S.p.A. (BIT:PRT) Fare As A Dividend Stock?

Mar 10
How Does Esprinet S.p.A. (BIT:PRT) Fare As A Dividend Stock?

Can You Imagine How Jubilant Esprinet's (BIT:PRT) Shareholders Feel About Its 155% Share Price Gain?

Feb 18
Can You Imagine How Jubilant Esprinet's (BIT:PRT) Shareholders Feel About Its 155% Share Price Gain?

How Much Of Esprinet S.p.A. (BIT:PRT) Do Insiders Own?

Feb 01
How Much Of Esprinet S.p.A. (BIT:PRT) Do Insiders Own?

Is It Too Late To Consider Buying Esprinet S.p.A. (BIT:PRT)?

Jan 18
Is It Too Late To Consider Buying Esprinet S.p.A. (BIT:PRT)?

Esprinet S.p.A.'s (BIT:PRT) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Jan 04
Esprinet S.p.A.'s (BIT:PRT) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Calculating The Fair Value Of Esprinet S.p.A. (BIT:PRT)

Dec 20
Calculating The Fair Value Of Esprinet S.p.A. (BIT:PRT)

These 4 Measures Indicate That Esprinet (BIT:PRT) Is Using Debt Reasonably Well

Dec 08
These 4 Measures Indicate That Esprinet (BIT:PRT) Is Using Debt Reasonably Well

Is There More To The Story Than Esprinet's (BIT:PRT) Earnings Growth?

Nov 24
Is There More To The Story Than Esprinet's (BIT:PRT) Earnings Growth?

Financial Position Analysis

Short Term Liabilities: PRT's short term assets (€1.5B) exceed its short term liabilities (€1.2B).

Long Term Liabilities: PRT's short term assets (€1.5B) exceed its long term liabilities (€221.2M).


Debt to Equity History and Analysis

Debt Level: PRT's net debt to equity ratio (55.8%) is considered high.

Reducing Debt: PRT's debt to equity ratio has increased from 49.2% to 83% over the past 5 years.

Debt Coverage: PRT's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: PRT's interest payments on its debt are not well covered by EBIT (2.1x coverage).


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 23:21
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Esprinet S.p.A. is covered by 9 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Fabrizio SpagnaAxia Financial Research
Dino CatenaEquita SIM S.p.A.
Pietro NargiIntermonte SIM S.p.A.